351 related articles for article (PubMed ID: 36579669)
21. Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment.
Ivey JW; Bonakdar M; Kanitkar A; Davalos RV; Verbridge SS
Cancer Lett; 2016 Sep; 380(1):330-9. PubMed ID: 26724680
[TBL] [Abstract][Full Text] [Related]
22. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
Salo T; Vered M; Bello IO; Nyberg P; Bitu CC; Zlotogorski Hurvitz A; Dayan D
Exp Cell Res; 2014 Jul; 325(2):58-64. PubMed ID: 24462456
[TBL] [Abstract][Full Text] [Related]
23. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
24. Significance of the Tumor Microenvironment in Liver Cancer Progression.
Muppala S
Crit Rev Oncog; 2020; 25(1):1-9. PubMed ID: 32865906
[TBL] [Abstract][Full Text] [Related]
25. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.
De P; Aske J; Sulaiman R; Dey N
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326670
[TBL] [Abstract][Full Text] [Related]
26. An emerging role for cellular crosstalk in the cancer stem cell niche.
Oshimori N; Guo Y; Taniguchi S
J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
[TBL] [Abstract][Full Text] [Related]
27. Microenvironmental Determinants of Pancreatic Cancer.
Hessmann E; Buchholz SM; Demir IE; Singh SK; Gress TM; Ellenrieder V; Neesse A
Physiol Rev; 2020 Oct; 100(4):1707-1751. PubMed ID: 32297835
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Tumor-Tumor Microenvironment Crosstalk.
Badve SS; Gökmen-Polar Y
Expert Opin Ther Targets; 2023; 27(6):447-457. PubMed ID: 37395003
[TBL] [Abstract][Full Text] [Related]
29. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
30. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
31. Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.
El-Tanani M; Rabbani SA; Babiker R; Rangraze I; Kapre S; Palakurthi SS; Alnuqaydan AM; Aljabali AA; Rizzo M; El-Tanani Y; Tambuwala MM
Cancer Lett; 2024 Jun; 591():216894. PubMed ID: 38626856
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between Tumor-Associated Macrophages and MicroRNAs: A Key Role in Tumor Microenvironment.
Zhou X; Chen B; Zhang Z; Huang Y; Li J; Wei Q; Cao D; Ai J
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362044
[TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
[TBL] [Abstract][Full Text] [Related]
34. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.
van der Heide CD; Dalm SU
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4616-4641. PubMed ID: 35788730
[TBL] [Abstract][Full Text] [Related]
35. The landscape of long non-coding RNAs in tumor stroma.
Uddin MN; Wang X
Life Sci; 2021 Jan; 264():118725. PubMed ID: 33166593
[TBL] [Abstract][Full Text] [Related]
36. Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies.
Han L; Xu J; Xu Q; Zhang B; Lam EW; Sun Y
Med Res Rev; 2017 Nov; 37(6):1318-1349. PubMed ID: 28586517
[TBL] [Abstract][Full Text] [Related]
37. Targeting Tumor Microenvironment for Cancer Therapy.
Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer.
Khan IR; Sadida HQ; Hashem S; Singh M; Macha MA; Al-Shabeeb Akil AS; Khurshid I; Bhat AA
Biomed Pharmacother; 2024 Jul; 176():116873. PubMed ID: 38843587
[TBL] [Abstract][Full Text] [Related]
39. Leveraging microenvironmental synthetic lethalities to treat cancer.
Metcalf KJ; Alazzeh A; Werb Z; Weaver VM
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720045
[TBL] [Abstract][Full Text] [Related]
40. Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for Thought.
Agostini A; Orlacchio A; Carbone C; Guerriero I
Front Immunol; 2022; 13():876291. PubMed ID: 35711414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
